Dante Labs
Regulation Crowdfunding offering on SeedInvest (SI Securities)
$536,190
of $1M goal
53.6% funded
About the offering
Dante Labs core product - the Whole Genome Sequencing - is one of the most complete DNA tests available in the market. We analyze people's DNA and then provide them with insights about hundreds of hereditary diseases, health conditions and traits. Why Dante Labs? Genetics is driving the next revolution in healthcare, by enabling personalized medicine and enhancing the discovery of new treatments. Genomic data is one of the most valuable data about people. However, it remains very hard for individuals to access their own genetic data, as genetic tests are usually only available offline. Expensive intermediaries, use of outdated technology by local labs, and bad capacity utilization generate an offer of low quality tests at inflated prices. Dante Labs makes ordering genetic tests as easy as buying a book on Amazon, and provides customers with clear and precise results. By removing intermediaries, leveraging global economies of scale, and developing internal data analysis, we pass cost savings to our customers, thus offering high quality at affordable prices. We developed internal data analysis tools to provide our customers with personalized reports and data analysis that perfectly fit their needs. Our bioinformatics pipeline becomes smarter every day as we enrich our knowledge with new proprietary data points.
FAQ
How much has Dante Labs raised?
Dante Labs has raised $536,190 of a $1M goal.
Where is Dante Labs's campaign listed?
The offering is listed on SeedInvest (SI Securities), an SEC-registered Reg CF intermediary.
What are the terms of Dante Labs's raise?
Convertible Debt, $6.5M cap, 20% discount, 5% interest.
When does Dante Labs's offering close?
The stated close date is Apr 20, 2018.
